AGREEMENTSchedule 13g Agreement • February 9th, 2024 • Frazier Life Sciences Public Fund, L.P. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 9th, 2024 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Adverum Biotechnologies, Inc.